Rapid In Vitro Assessment of Antimicrobial Drug Effect Bridging Clinically Relevant Pharmacokinetics: A Comprehensive Methodology.
Autorzy:
Nikolaou M; Chemical & Biomolecular Engineering Department, University of Houston, Houston, TX 77204, USA. TamVH; Chemical & Biomolecular Engineering Department, University of Houston, Houston, TX 77204, USA.; Department of Pharmacy Practice & Translational Research, University of Houston, Houston, TX 77204, USA.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2023 Jun 07; Vol. 15 (6). Date of Electronic Publication: 2023 Jun 07.
Optimizing Clinical Outcomes Through Rational Dosing Strategies: Roles of Pharmacokinetic/Pharmacodynamic Modeling Tools.
Autorzy:
Chua HC; Department of Pharmacy, CHI Baylor St. Luke's Medical Center, Houston, Texas, USA.; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA. TamVH; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Dec 16; Vol. 9 (12), pp. ofac626. Date of Electronic Publication: 2022 Dec 16 (Print Publication: 2022).
Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii .
Autorzy:
Bai B; Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, The 6th Affiliated Hospital of Shenzhen University Health Center, Shenzhen, Guangdong, China.; Department of Pharmacy Practice and Translational Research, University of Houston, Houston, Texas, USA. Eales BM; Department of Pharmacy Practice and Translational Research, University of Houston, Houston, Texas, USA. Huang W; Bacteriology & Antibacterial Resistance Surveillance Laboratory, Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China. Ledesma KR; Department of Pharmacy Practice and Translational Research, University of Houston, Houston, Texas, USA. Merlau PR; Department of Pharmacy Practice and Translational Research, University of Houston, Houston, Texas, USA. Li G; Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, The 6th Affiliated Hospital of Shenzhen University Health Center, Shenzhen, Guangdong, China. Yu Z; Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, The 6th Affiliated Hospital of Shenzhen University Health Center, Shenzhen, Guangdong, China.; Department of Pharmacy Practice and Translational Research, University of Houston, Houston, Texas, USA. TamVH; Department of Pharmacy Practice and Translational Research, University of Houston, Houston, Texas, USA.
Pokaż więcej
Źródło:
Virulence [Virulence] 2022 Dec; Vol. 13 (1), pp. 1920-1927.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases.
Autorzy:
Wong CL; Department of Medicine and Geriatrics, Caritas Medical Centre, Shamshuipo, Kowloon, Hong Kong. Fok CK; Department of Medicine and Geriatrics, Caritas Medical Centre, Shamshuipo, Kowloon, Hong Kong. Chan YK; Department of Medicine and Geriatrics, Pok Oi Hospital, Yuen Long, The New Territories, Hong Kong. TamVH; Department of Medicine and Geriatrics, Caritas Medical Centre, Shamshuipo, Kowloon, Hong Kong. Fung LM; Department of Medicine and Geriatrics, Caritas Medical Centre, Shamshuipo, Kowloon, Hong Kong.
Pokaż więcej
Źródło:
Case reports in endocrinology [Case Rep Endocrinol] 2022 Sep 14; Vol. 2022, pp. 7395050. Date of Electronic Publication: 2022 Sep 14 (Print Publication: 2022).
An integrated approach to evaluate different tetracycline derivatives for formulary decisions.
Autorzy:
Zidaru A; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA. Phe K; Department of Pharmacy, Baylor St. Luke's Medical Center, Houston, TX, USA. Lasco TM; Department of Pathology, Baylor St. Luke's Medical Center, Houston, TX, USA. TamVH; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA.
Corrigendum to " In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways".
Autorzy:
Skoglund E; University of Houston College of Pharmacy, Houston, TX, USA. Abodakpi H; University of Houston College of Pharmacy, Houston, TX, USA. Rios R; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA. Diaz L; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Millennium Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago, Chile. De La Cadena E; Grupo de Investigación en Resistencia Antimicrobiana y Epidemiología Hospitalaria-RAEH, Universidad El Bosque, Bogotá, Colombia. Dinh AQ; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA. Ardila J; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia. Miller WR; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA. Munita JM; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Millennium Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago, Chile.; Genomics and Resistant Microbes Group, Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Santiago, Chile. Arias CA; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA.; Department of Microbiology and Molecular Genetics, UTHealth McGovern Medical School, Houston, TX, USA.; Center for Infectious Diseases, University of Texas School of Public Health, Houston, TX, USA. TamVH; University of Houston College of Pharmacy, Houston, TX, USA. Tran TT; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA.
Pokaż więcej
Źródło:
Case reports in infectious diseases [Case Rep Infect Dis] 2019 Sep 02; Vol. 2019, pp. 8314349. Date of Electronic Publication: 2019 Sep 02 (Print Publication: 2019).
In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways.
Autorzy:
Skoglund E; University of Houston College of Pharmacy, Houston, TX, USA. Abodakpi H; University of Houston College of Pharmacy, Houston, TX, USA. Rios R; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA. Diaz L; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Millennium Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago, Chile. De La Cadena E; Grupo de Investigación en Resistencia Antimicrobiana y Epidemiología Hospitalaria - RAEH, Universidad El Bosque, Bogotá, Colombia. Dinh AQ; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA. Ardila J; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia. Miller WR; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA. Munita JM; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Millennium Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago, Chile.; Genomics and Resistant Microbes Group, Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Santiago, Chile. Arias CA; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogotá, Colombia.; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA.; Department of Microbiology and Molecular Genetics, UTHealth McGovern Medical School, Houston, TX, USA.; Center for Infectious Diseases, University of Texas School of Public Health, Houston, TX, USA. TamVH; University of Houston College of Pharmacy, Houston, TX, USA. Tran TT; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, TX, USA.; Division of Infectious Diseases, UTHealth McGovern Medical School, Houston, TX, USA.
Pokaż więcej
Źródło:
Case reports in infectious diseases [Case Rep Infect Dis] 2018 Dec 23; Vol. 2018, pp. 9095203. Date of Electronic Publication: 2018 Dec 23 (Print Publication: 2018).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
